Author Linington, Christopher

• 2001 | Journal Article
  ​ ​Analysis of interleukin-4 receptor alpha chain variants in multiple sclerosis​
  Hackstein, H.; Bitsch, A.; Bohnert, A.; Hofmann, H.-S.; Weber, F.; Ohly, A. & Linington, C. et al.​ (2001) 
  Journal of Neuroimmunology, 113(2) pp. 240​-248​.​ DOI: https://doi.org/10.1016/S0165-5728(00)00455-0 
  ​Details  DOI  PMID  PMC  WoS 

• 2004 | Journal Article
  ​ ​Targeting experimental autoimmune encephalomyelitis lesions to a predetermined axonal tract system allows for refined behavioral testing in an animal model of multiple sclerosis​
  Kerschensteiner, M.; Stadelmann, C. ; Buddeberg, B. S.; Merkler, D.; Bareyre, F. M.; Anthony, D. C. & Linington, C. et al.​ (2004) 
  American Journal Of Pathology, 164(4) pp. 1455​-1469​.​ DOI: https://doi.org/10.1016/S0002-9440(10)63232-4 
  ​Details  DOI  PMID  PMC  WoS 

• 2004 | Journal Article
  ​ ​The activation status of neuroantigen-specific T cells in the target organ determines the clinical outcome of autoimmune encephalomyelitis​
  Kawakami, N.; Lassmann, S.; Li, Z.; Odoardi, F. ; Ritter, T.; Ziemssen, T. & Klinkert, W. E F et al.​ (2004) 
  Journal of Experimental Medicine, 199(2) pp. 185​-197​.​ DOI: https://doi.org/10.1084/jem.20031064 
  ​Details  DOI  PMID  PMC 

• 2006 | Review
  ​ ​Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research​
  Gold, R.; Linington, C.& Lassmann, H.​ (2006)
  Brain, 129​ pp. 1953​-1971​.​
  Oxford Univ Press. DOI: https://doi.org/10.1093/brain/awl075 
  ​Details  DOI  PMID  PMC  WoS 

• 2015 | Conference Abstract
  ​ ​The role of fibroblast growth factor 9 in multiple sclerosis: inhibition of myelination and induction of pro-inflammatory environment​
  Thuemmler, K.; Lindner, M.; Stadelmann, C. ; Lassmann, H.; Schaeren-Wiemers, N.; Meinl, E. & Linington, C.​ (2015)
  Glia, 63 , Bilbao, SPAIN.
  Hoboken​: Wiley-blackwell.
  ​Details  WoS 

• 2015 | Journal Article
  ​ ​Fibroblast growth factor signalling in multiple sclerosis: inhibition of myelination and induction of pro-inflammatory environment by FGF9​
  Lindner, M.; Thuemmler, K.; Arthur, A.; Brunner, S.; Elliott, C.; McElroy, D. & Mohan, H. et al.​ (2015) 
  Brain, 138 pp. 1875​-1893​.​ DOI: https://doi.org/10.1093/brain/awv102 
  ​Details  DOI  PMID  PMC  WoS 

• 2017 | Journal Article | 
  ​ ​Differential contribution of immune effector mechanisms to cortical demyelination in multiple sclerosis​
  Lagumersindez-Denis, N.; Wrzos, C.; Mack, M.; Winkler, A.; van der Meer, F.; Reinert, M.-C. & Hollasch, H.  et al.​ (2017) 
  Acta Neuropathologica, 134(1) pp. 15​-34​.​ DOI: https://doi.org/10.1007/s00401-017-1706-x 
  ​Details  DOI  PMID  PMC  WoS 

• 2018 | Journal Article
  ​ ​Preclinical stress originates in the rat optic nerve head during development of autoimmune optic neuritis​
  Stojic, A.; Bojcevski, J.; Williams, S. K.; Bas-Orth, C.; Nessler, S. ; Linington, C. & Diem, R.  et al.​ (2018) 
  Glia, 67(3) pp. 512​-524​.​ DOI: https://doi.org/10.1002/glia.23560 
  ​Details  DOI 

• 2022 | Journal Article
  ​ ​SARM1 Depletion Slows Axon Degeneration in a CNS Model of Neurotropic Viral Infection​
  Crawford, C. L.; Antoniou, C.; Komarek, L.; Schultz, V.; Donald, C. L.; Montague, P. & Barnett, S. C. et al.​ (2022) 
  Frontiers in Molecular Neuroscience, 15 art. 860410​.​ DOI: https://doi.org/10.3389/fnmol.2022.860410 
  ​Details  DOI 

• 2023 | Journal Article
  ​ ​Fibroblast growth factor 9 (FGF9) mediated neurodegeneration: implications for progressive multiple sclerosis?​
  Thümmler, K.; Wrzos, C.; Franz, J.; McElroy, D.; Cole, J. J.; Hayden, L. & Arseni, D. et al.​ (2023) 
  Neuropathology and Applied Neurobiology, art. e12935​.​ DOI: https://doi.org/10.1111/nan.12935 
  ​Details  DOI  PMID  PMC 

Researcher

Sort

Items per Page